Even more convincingly, the current findings are consistent with our previous research [41,51], indicating that bioactive compounds found in rooibos generally show comparative effects as that of accomplished antidiabetic therapies such as metformin and insulin in ameliorating metabolic disease-associated complications in preclinical models. The gene discussed is INS; the disease is metabolic disease.